UK Regulators Approve World’s First DMT for Depression Clinical Trial

Small Pharma receives regulatory approval for clinical trial to explore DMT for depression, which it claims is the world’s first patient clinical trial of the psychedelic. London-based Small Pharma has been given the green light by UK regulators for a trial assessing the safety, and later efficacy, of N,N-dimethyltryptamine (DMT) in depression. The company believes … Continue reading UK Regulators Approve World’s First DMT for Depression Clinical Trial